Black community members, scientists object to plan to bury skulls from Philadelphia museum
By Lizzie Wade,
Science
| 01. 23. 2024
For nearly 2 centuries, the skulls of 20 Black people who died in Philadelphia have formed part of the Morton Cranial Collection, now housed at the University of Pennsylvania (UPenn) Museum of Archaeology and Anthropology. Most of the skulls were collected by physical anthropologist Samuel Morton, who in the 1830s and ’40s amassed hundreds of them for studies he designed to identify supposed biological racial differences and scientifically prove what he believed to be the inferiority of nonwhite people. On 3 February, the museum plans to lay the crania of 19 of the Black Philadelphians in the collection to rest in a historically Black cemetery. “After 200 years of being on display and subject to scientific testing, these individuals deserve an interment with all the dignity and respect that we can give them,” says Penn Museum Director Christopher Woods. “They don’t belong in the museum.”
But a self-identified descendant community group and multiple anthropologists say the museum has not lived up to its promise to repatriate the remains and has failed to do sufficient archival research into the identities of...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...